Tag Archives: Trial

NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »

‘Unexpected finding’ killed vaccine trial

Prime Minister Scott Morrison announced on Friday it has terminated its $ 1 billion deal for the vaccine candidate being developed by the University of Queensland (UQ) and global biotech company CSL because trial participants were returning false-positive HIV test results. There were fears these results could undermine confidence in other vaccine candidates, so the… Read More »

CureVac COVID-19 Vaccine Induces Immune Response in Early Trial

Berlin, November 2: German vaccine maker CureVac on Monday said that interim results from early trials showed that its investigational Covid-19 vaccine candidate, CvnCoV, appeared safe and triggered immune response among volunteers. The vaccine candidate was generally well tolerated across all tested doses and induced strong binding and neutralising antibody responses in addition to first… Read More »

Covid-19 news: Russian vaccine induced immune responses in small trial

By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Sputnik V, Gamaleya National CenterTHE RUSSIAN DIRECT INVESTMENT FUND Latest coronavirus news as of 5 pm on 4 September Russia’s vaccine candidate produced antibody and T-cell responses in early-stage trial A preliminary trial of Russia’s coronavirus… Read More »

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine – nejm.org

Trial Population Table 1. Table 1. Demographic Characteristics of the Participants in the NVX-CoV2373 Trial at Enrollment. The trial was initiated on May 26, 2020; 134 participants underwent randomization between May 27 and June 6, 2020, including 3 participants who were to serve as backups for sentinel dosing and who immediately withdrew from the trial… Read More »